APA (7th ed.) Citation

Kuwano, A., Yada, M., Kurosaka, K., Tanaka, K., Masumoto, A., & Motomura, K. (2023). Risk factors for loss to follow‐up after the start of direct‐acting antiviral treatment for hepatitis C virus infection. Wiley.

Chicago Style (17th ed.) Citation

Kuwano, Akifumi, Masayoshi Yada, Kazuki Kurosaka, Kosuke Tanaka, Akihide Masumoto, and Kenta Motomura. Risk Factors for Loss to Follow‐up After the Start of Direct‐acting Antiviral Treatment for Hepatitis C Virus Infection. Wiley, 2023.

MLA (9th ed.) Citation

Kuwano, Akifumi, et al. Risk Factors for Loss to Follow‐up After the Start of Direct‐acting Antiviral Treatment for Hepatitis C Virus Infection. Wiley, 2023.